Friday, Feb 25, 2005

Genentech Announces March 4 Webcast of Investment Community Meeting

South San Francisco, Calif. -- February 25, 2005 --

Genentech, Inc. (NYSE:DNA) invites investors, the media and the general public to listen to a live audio webcast of its investment community meeting in New York. The webcast will begin on Friday, March 4, 2005 at 8:00 a.m. Eastern Time. The meeting is expected to last approximately four and a half hours.

The webcast can be accessed on Genentech's web site at and will be archived and available for replay until 8:00 p.m. Eastern Time on March 18, 2005.

Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for significant unmet medical needs. A considerable number of the currently approved biotechnology products originated from, or are based on, Genentech science. Genentech manufactures and commercializes multiple biotechnology products directly in the United States, and receives royalties or other income from companies that are licensed to market its products outside of the United States. The company has headquarters in South San Francisco, Calif., and is traded on the New York Stock Exchange under the symbol DNA. For additional information about the company, please visit